But theres a catch: Although both brand-name medications contain the same GLP-1 agonist, Mounjaro and Zepbound are not approved to treat the exact same conditions
No batch tracking or recall pathways If a contaminated vial causes an infection or systemic reaction, you may have no qualitycontrol paper trail
The session, Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon Receptor TriagonistObesity, NAFLD, and T2D Phase 2 Trial Results , can be viewed on-demand by registered meeting participants at ADA2023.org
In receptor binding studies, it has been shown to have a GLP-1R and GLP-1 binding affinity, respectively, about five times lower than that of native and similar to endogenous GIP (40)
Your provider will discuss appropriate treatment options during your consultation and determine whether Semaglutide is suitable based on your health history and goals